Interesting comaprisons...
ORC = 4.3c
ORCO = 1.1c (30/11/06)
ARO = 3.9c
AROOB = 1.3c (30/11/12)
RRS = 4c (adjusted for rights issue; currently 5.2)
RRSO = 1.3c (1/10/07)
PNO = 5.6c
PNOO = 1.7c (31/12/06 - 5c)
Clearly, PNOO is undervalued by at least half a cent...however this doesn't mean the market is wrong.
There are obviously doubts about the recent announcement and possibly even concerns about the possible efficacy and therefore, marketability of Tripetofen.
Should the company address either of these issues with a positive announcement, I would expect the market might have a change of heart.
Cheers!
interesting comparisons...
Add CAI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $93.67M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.5¢ | $87.23K | 795.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 392023 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 560013 | 7 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
11.0¢ |
Change
0.005 ( 2.33 %) |
||||
| Open | High | Low | Volume | ||
| 10.8¢ | 11.5¢ | 10.8¢ | 361300 | ||
| Last updated 15.36pm 13/06/2024 ? | |||||
| CAI (ASX) Chart |